The Texas A&M university system’s bio-manufacturing center is slated to start manufacturing a coronavirus vaccine candidate early next year. FUJIFILM Diosynth Biotechnologies (FDB), which is the A&M system’s subcontractor, will mass produce the vaccine candidate [Read More…]
The post Texas A&M System And FUJIFILM Diosynth Biotechnologies Receive Federal Contract To Mass Produce A Coronavirus Vaccine Candidate In Early 2021 appeared first on WTAW | 1620AM & 94.5FM.